Technology

Advancements enable better diagnosis, treatment of patients.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part three.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part two.

The company intends to develop the AcuStream technology for potential use with its current and future front-of-eye therapies, which may include lifitegrast ophthalmic solution for the treatment of dry eye disease.

Mojo Vision's CEO Drew Perkins announced last week that he became the first, and currently only, person to wear the latest prototype of Mojo Lens, an augmented reality-based contact lens.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part one.

Knowing your glaucoma vitals is key to providing best treatment for patients.

Embracing this new model of care can allow optometric practices to flourish—and may enable earlier detection of conversion from intermediate dry to wet AMD.

The amount of light effused by these round-shaped eyeglass frames are designed to match the exact wavelength of sunlight a user would be exposed to outside.

The company's technology allows for ECPs to detect, monitor, and treat AMD 3 years before clinical diagnosis.

A prototype of a visually-guided hearing aid (VGHA) designed at Boston University of a the formed beam is manipulated by eye gaze to improve the ability of users of the technology to better focus on one sound despite the presence of nearby competing sounds.

Optimizing eye care for pilots is crucial for safe flying.

Advice for pilots to consider ahead of taking flight.

Wearable devices and multifunctional instruments provide in-office advantages

As an all-in-one handheld device, eyecare practitioners can tailor patients’ needs for MGD treatment in both eyes in approximately 8 to 12 minutes.

Heru Chief Marketing Officer Brandon Barber speaks on the company's upcoming advancements and two new testing modalities on its diagnostic platform: Fast Pattern Suprathreshold Visual Field and the Farnsworth D-15 extended color vision exam.

Education, advancing technology are key to meeting patient needs

With its portable capabilities, the Heru platform replaces legacy diagnostic devices and surpasses standard care in cost and size.

Breakthrough film technology stops lenses from fogging faster than the blink of an eye

The company expects to enroll patients diagnosed with keratoconus in two trials at clinical sites in the US, South America, Europe, and Asia.

The new anti-reflective lens coating outperforms its predecessors by up to 70%

Understanding legal, regulatory issues is crucial as telehealth use widens

Sustained-release injectables may be key to addressing the greatest obstacles in glaucoma.

Oluwatosin U. Smith, MD, speaks shares the highlights of her presentation exploring remote monitoring of glaucoma and the future of virtual care on the whole.

Ranya Habash, MD, shares a sneek peek of her New Horizions keynote speech on "The future of eye care: science fiction to science fact," during the 2022 Glaucoma 360 meeting.

As consistent use of digital devices remains a fact of life for people of virtually all ages, consider this expert advice

Advancements in medications and lasers bring better adherence and outcomes.

Expand your business by administering injectable treatments.

Electronic health records may be the future of practice management.